Home > News > Labopharm reports results for third quarter fiscal 2004
October 28th, 2004
Labopharm reports results for third quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the third quarter of fiscal 2004 ended
September 30, 2004. Net loss for the third quarter of fiscal 2004 was $5.9 million, or $0.14
per share, compared with $7.9 million, or $0.22 per share, for the third quarter of fiscal 2003.
Source:
prnewswire
Related Links |
Related News Press |
Announcements
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |